Junk DNA” may hold the key to treating tough cancers. Existing drugs exploit weaknesses in cells with gene mutations. Researchers at King’s College London have identified a promising strategy for ...

Professor Alexander Hoffmann and Genhong Cheng from University of California, Los Angeles, jointly with Professor David ...

Noonan syndrome with multiple lentigines (NSML) is a rare genetic disorder that causes short stature, distinctive facial ...

RNAConnect, a leader in next-generation molecular biology tools, today announced the commercial launch of the UltraMarathonRT cDNA Synthesis and Amplification Kit, designed to elevate short-read RNA ...

Researchers from King's have identified a new way to treat certain blood cancers using existing drugs, by turning a once-dismissed part of our DNA into a therapeutic target.

Discover a study uncovering how G3BP1 regulates autophagy and lipid metabolism in MASLD, offering a promising new therapeutic ...

Researchers from MIT have incorporated several modifications to prime editing systems, making them up to 60 times more ...

Study led by CureShank Aims to characterize the direct and indirect burden of PMS to patients, caregivers, and US healthcare system MADRID and ...

It's a pretty longer protein. So the literature reports generally guide to a multi-day, potentially 2-week half-life. And once the protein is made, it is thought to be stably incorporated into the ...

This valuable study analyzes aging-related chromatin changes through the lens of intra-chromosomal gene correlation length, which is a novel computational metric that captures spatial correlations in ...

Penny Patterson VP, Corporate Affairs Promega Corporation Phone: (608) 274-4330 E-mail: [email protected] Promega Corporation has entered a strategic partnership with Watchmaker Genomics to ...